Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

ICICI Lombard General Insurance Company - Health segment faces short-term challenges; long-term fundamentals remain intact - ICICI Securities

Posted On: 2021-01-20 22:36:07 (Time Zone: Arizona, USA)


Health segment of ICICI Lombard (ICICIGI) will have to reorient its product and channel mix as the principal bancassurance partner (ICICI Bank) is focusing less on sale of credit-linked attachment products. This can pose near-term challenge in growth of health segment (ICICIGI health segment witnessed a decline of 3.9%YoY in 9MFY21 vs industry growth of 13.7% YoY). However, with focus on retail sales, new partnerships, new products and favourable base, we expect ICICIGI to recover health segment growth in FY22E/FY23E. With recovery of premium growth in motor and expected price hikes in motor TP along with the market share gain already achieved in motor/P&C, ICICIGI is expected to be able to maintain business constructs of 15-18% premium growth with 100% combined ratio. This should lead to Rs20bn PAT in FY23E (19% CAGR between FY20-FY23E) with RoE of ~20%. Post the 23% rally in price in past 3 months, we downgrade the stock from Buy to ADD with a target price of Rs1,584, implying 36x FY22E EPS of ~Rs43.8.

- Expectation remains around ~Rs15bn PAT in FY21E and Rs20bn in FY23E. We estimate Rs14.8bn PAT in FY21E on the back of: 1) the 13% NEP growth in Q4FY21 vs 4% in 9MFY21; 2) 69.7% loss ratio in Q4FY21 (67.5% in 9MFY21); 3) 28.6% opex ratio (commission plus expense) (32% opex ratio in 9MFY21 {average opex ratio in FY17-FY20 was 24%}); and 4) Rs6.1bn investment income in Q4FY21 (Rs16.5bn / Rs5.8bn in 9MFY21 / Q3FY21).

- Market share gain in motor and P&C is a typical countercyclical business strength of ICICIGI. ICICIGI gained 1.1% YoY market share in motor segment. Within P&C segment, ICICIGI gained 1%/1.2%/1% in Fire / Engineering / Marine Cargo respectively.

- Prudent reserving the highlight of 9MFY21. Despite the significant fluctuations in business activity and in turn claims, motor TP loss ratios have remained between 62-70%, motor OD loss ratios between 59-63% and health between 75-82% over the first three quarters of FY21. This has obviously been driven by prudent reserving (change in 'claims reserve to total claims' ratio) decreasing gradually from 33% in Q1FY21 to 27% in Q2FY21 and 8% in Q3FY21.

- Strong execution and robust balance sheet will benefit ICICIGI. ICICIGI has managed strong organic expansion with agents increasing from 35,729 in FY19 to 55,615 in Q3FY21 and virtual offices increasing from 135 in FY18 to 840 in Q3FY21. Company has also embarked on inorganic growth with the acquisition of Bharti Axa, which had 1.7% GDPI market share in FY20. It also acquired AutoNinja (CRM software for auto dealers) in Nov'19, which has helped renewal rate in motor insurance). This superior execution track record will be further aided by strong balance sheet with solvency of 2.76x as of 9MFY21 and an AUM including fair value change amount of Rs299bn (equity exposure remains ~10.9%). 47% of non-life insurers (based on GDPI) had less than 1.8x solvency ratio as of Q4FY20.

- Downgrade from Buy to ADD. The shift in sales strategy of ICICI Bank to reduced sale of credit-linked attachment products is a negative surprise for ICICIGI. ICICIGI is expected to address the same through new tie-ups, new products (better pricing with wider coverage) and increased focus on retail sales. However, this one-time reset in distribution mix will have a near-term impact on growth.

Shares of ICICI Lombard General Insurance Company Ltd was last trading in BSE at Rs.1495.05 as compared to the previous close of Rs. 1509.45. The total number of shares traded during the day was 83399 in over 6069 trades.

The stock hit an intraday high of Rs. 1505 and intraday low of 1452.8. The net turnover during the day was Rs. 122677868.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world

Initiating Coverage - Dalmia Bharat Ltd - HDFC Securities Retail Research Desk



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020